Хайлтын үр дүнгүүд - Naveen Pemmaraju

Үр дүнг сайжруулах
  1. 1
    Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm

    Approval of tagraxofusp-erzs for blastic plasmacytoid dendritic cell neoplasm -н Naveen Pemmaraju, Marina Konopleva

    Хэвлэсэн 2020
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    FLT3 inhibitors in the treatment of acute myeloid leukemia

    FLT3 inhibitors in the treatment of acute myeloid leukemia -н Naveen Pemmaraju, Hagop M. Kantarjian, Farhad Ravandi, Jorge E. Cortés

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects

    Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects -н Naveen Pemmaraju, Mark F. Munsell, G. N. Hortobagyi, Sharon H. Giordano

    Хэвлэсэн 2011
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer

    Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer -н Miguel‐Angel Perales, Emily K. Drake, Naveen Pemmaraju, William A. Wood

    Хэвлэсэн 2016
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy

    Ten years after ruxolitinib approval for myelofibrosis: a review of clinical efficacy -н Naveen Pemmaraju, Prithviraj Bose, Raajit K. Rampal, Aaron T. Gerds, Angela Fleischman, Srđan Verstovšek

    Хэвлэсэн 2023
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Erythroleukemia-historical perspectives and recent advances in diagnosis and management

    Erythroleukemia-historical perspectives and recent advances in diagnosis and management -н Prajwal Boddu, Christopher B. Benton, Wei Wang, Gautam Borthakur, Joseph D. Khoury, Naveen Pemmaraju

    Хэвлэсэн 2017
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Is acute myeloid leukemia a liquid tumor?

    Is acute myeloid leukemia a liquid tumor? -н Maro Ohanian, Stefan Faderl, Farhad Ravandi, Naveen Pemmaraju, Guillermo Garcia‐Manero, Jorge E. Cortés, Zeev Estrov

    Хэвлэсэн 2013
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Real-world treatments and thrombotic events in polycythemia vera patients in the USA

    Real-world treatments and thrombotic events in polycythemia vera patients in the USA -н Srđan Verstovšek, Naveen Pemmaraju, Nancy L. Reaven, Susan E. Funk, Tracy Woody, Frank H. Valone, Suneel Gupta

    Хэвлэсэн 2023
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  9. 9
    Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia

    Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia -н Naveen Pemmaraju, Aaron T. Gerds, Jingbo Yu, Shreekant Parasuraman, Anne Shah, Ann Xi, Shambhavi Kumar, Robyn M. Scherber, Srđan Verstovšek

    Хэвлэсэн 2022
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  10. 10
    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis -н Lucia Masárová, Ahmad Alhuraiji, Prithviraj Bose, Naval Daver, Naveen Pemmaraju, Jorge E. Cortés, Sherry Pierce, Hagop M. Kantarjian, Srđan Verstovšek

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  11. 11
    Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders

    Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders -н Barry Stein, Donna M. Williams, Nae‐Yuh Wang, Ophelia Rogers, Mark A. Isaacs, Naveen Pemmaraju, Jerry L. Spivak, Alison R. Moliterno

    Хэвлэсэн 2010
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  12. 12
    Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis

    Patients with post-essential thrombocythemia and post-polycythemia vera differ from patients with primary myelofibrosis -н Lucia Masárová, Prithviraj Bose, Naval Daver, Naveen Pemmaraju, Kate J. Newberry, Taghi Manshouri, Jorge E. Cortés, Hagop M. Kantarjian, Srđan Verstovšek

    Хэвлэсэн 2017
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  13. 13
    Improved survival of patients with myelofibrosis in the last decade: Single‐center experience

    Improved survival of patients with myelofibrosis in the last decade: Single‐center experience -н Lucia Masárová, Prithviraj Bose, Naveen Pemmaraju, Naval Daver, Koji Sasaki, Helen T. Chifotides, Lingsha Zhou, Hagop M. Kantarjian, Zeev Estrov, Srđan Verstovšek

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  14. 14
    Defining disease modification in myelofibrosis in the era of targeted therapy

    Defining disease modification in myelofibrosis in the era of targeted therapy -н Naveen Pemmaraju, Srđan Verstovšek, Ruben A. Mesa, Vikas Gupta, Jacqueline S. Garcia, Joseph M. Scandura, Stephen T. Oh, Francesco Passamonti, Konstanze Döhner, Adam J. Mead

    Хэвлэсэн 2022
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  15. 15
    Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel

    Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel -н Livio Pagano, Pier Luigi Zinzani, Stefano Pileri, Pietro Quaglino, Branko Cuglievan, Emilio Berti, Naveen Pemmaraju, Francesco Onida, Rein Willemze, Alberto Órfão, Giovanni Barosi

    Хэвлэсэн 2023
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  16. 16
    Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy

    Characteristics of patients with myeloproliferative neoplasms with lymphoma, with or without JAK inhibitor therapy -н Naveen Pemmaraju, Hagop M. Kantarjian, Loretta J. Nastoupil, Megan Dupuis, Lisa Zhou, Sherry Pierce, Keyur P. Patel, Lucia Masárová, Jorge E. Cortés, Srđan Verstovšek

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  17. 17
    Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phase

    Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid... -н Talha Badar, Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Gautam Borthakur, Jorge E. Cortés, Naveen Pemmaraju, Sherry R. Pierce, Kate J. Newberry, Naval Daver, Srđan Verstovšek

    Хэвлэсэн 2015
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  18. 18
    Final results of a phase 2, open‐label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic syndrome

    Final results of a phase 2, open‐label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high‐risk myelodysplastic s... -н Rita Assi, Hagop M. Kantarjian, Tapan M. Kadia, Naveen Pemmaraju, Elias Jabbour, Nitin Jain, Naval Daver, Zeev Estrov, Taisuke Uehara, Takashi Owa, Jorge E. Cortés, Gautam Borthakur

    Хэвлэсэн 2018
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  19. 19
    Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm

    Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual... -н Wei Wang, Joseph D. Khoury, Roberto N. Miranda, Jeffrey L. Jorgensen, Jie Xu, Sanam Loghavi, Shaoying Li, Naveen Pemmaraju, Than Nguyen, L. Jeffrey Medeiros, Sa A. Wang

    Хэвлэсэн 2020
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  20. 20
    Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs

    Single-center experience with venetoclax combinations in patients with newly diagnosed and relapsed AML evolving from MPNs -н Lucia Masárová, Courtney D. DiNardo, Prithviraj Bose, Naveen Pemmaraju, Naval Daver, Tapan M. Kadia, Helen T. Chifotides, Lingsha Zhou, Gautam Borthakur, Zeev Estrov, Marina Konopleva, Srđan Verstovšek

    Хэвлэсэн 2021
    Бүрэн текст авах Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: